Phase III study comparing gefitinib monotherapy (G) to combination therapy with gefitinib, carboplatin, and pemetrexed (GCP) for untreated patients (pts) with advanced non-small cell lung cancer (NSCLC) with EGFR mutations (NEJ009).

被引：76
|
作者：
Nakamura, Atsushi
Inoue, Akira
Morita, Satoshi
Hosomi, Yukio
Kato, Terufumi
Fukuhara, Tatsuro
Gemma, Akihiko
Takahashi, Kazuhisa
Fujita, Yuka
Harada, Toshiyuki
Minato, Koichi
Takamura, Kei
Kobayashi, Kunihiko
Nukiwa, Toshihiro
机构：
[1] Sendai Kousei Hosp, Sendai, Miyagi, Japan
[2] Tohoku Univ, Dept Palliat Med, Sch Med, Sendai, Miyagi, Japan
[3] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan
[4] Komagome Hosp, Dept Thorac Oncol & Resp Med, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[5] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa, Japan
[6] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi, Japan
[7] Nippon Med Sch, Dept Pulm Med & Oncol, Tokyo, Japan
[8] Juntendo Univ, Dept Resp Med, Sch Med, Tokyo, Japan
[9] Natl Hosp Org Asahikawa Med Ctr, Dept Resp Med, Asahikawa, Hokkaido, Japan
[10] JCHO Hokkaido Hosp, Dept Resp Med, Sapporo, Hokkaido, Japan
[11] Gunma Prefectural Canc Ctr, Div Resp Med, Ota, Japan
[12] Obihiro Kosei Gen Hosp, Dept Med 1, Obihiro, Hokkaido, Japan
[13] Saitama Med Univ Int Med Ctr, Dept Resp Med, Hidaka, Japan
[14] Tohoku Univ, Dept Resp Med, Sendai, Miyagi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9005
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Gefitinib: Phase II and III results in advanced non-small cell lung cancer
    Kelly, K
    Averbuch, S
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 93 - 99
  • [42] Anlotinib with gefitinib as first-line therapy in advanced non-small cell lung cancer harboring EGFR mutations: A phase II study
    Ji, Y.
    Wang, X.
    Lou, Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S979 - S979
  • [43] PHASE I-II STUDY OF IRINOTECAN (CPT-11) AND GEFITINIB IN PATIENTS (PTS) WITH GEFITINIB FAILURE FOR NON-SMALL CELL LUNG CANCER (NSCLC)
    Horiike, A.
    Ohyanagi, F.
    Kudo, K.
    Miyauchi, E.
    Kasahara, K.
    Horai, T.
    Nishio, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 108 - 108
  • [44] First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: A phase III study (002) by North East Japan Gefitinib Study Group
    Kobayashi, K.
    Inoue, A.
    Maemondo, M.
    Sugawara, S.
    Isobe, H.
    Oizumi, S.
    Saijo, Y.
    Gemma, A.
    Morita, S.
    Hagiwara, K.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Study of Gefitinib and Pemetrexed as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation
    An, Chaolun
    Zhang, Jiajun
    Chu, Hongjun
    Gu, Chunyan
    Xiao, Feng
    Zhu, Fengwei
    Lu, Rujian
    Shi, Hai
    Zhang, Hongfei
    Yi, Xin
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (04) : 763 - 768
  • [46] A PHASE II TRIAL OF PEMETREXED (P), GEMCITABINE (G), AND BEVACIZUMAB (BV) IN UNTREATED PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Wozniak, Antoinette
    Kalemkerian, Gregory
    Gadgeel, Shirish M.
    Ramnath, Nithya
    Schneider, Bryan
    Valdivieso, Manuel
    Smith, Daryn
    Hackstock, Deborah
    Chen, Wei
    Ruckdeschel, John
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1234 - S1235
  • [47] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Wozniak, A. J.
    Kalemkerian, G. P.
    Gadgeel, S. M.
    Schneider, B. J.
    Valdivieso, M.
    Venkatramanamoorthy, R.
    Hackstock, D. M.
    Chen, W.
    Heilbrun, L. K.
    Ruckdeschel, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Wozniak, Antoinette J.
    Kalemkerian, Gregory P.
    Gadgeel, Shirish M.
    Schneider, Bryan J.
    Valdivieso, Manuel
    Smith, Daryn
    Hackstock, Deborah M.
    Chen Wei
    Heilbrun, Lance K.
    Ruckdeschel, John D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S454 - S454
  • [49] Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
    Kim, Young Saing
    Cho, Eun Kyung
    Woo, Hyun Sun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Inkeun
    Sym, Sun Jin
    Kyung, Sun Young
    Kang, Shin Myung
    Park, Jeong-Woong
    Jeong, Sung Hwan
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 80 - 87
  • [50] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Meng-zhao
    中华医学杂志(英文版), 2006, (01) : 63 - 68
12345